Impedimed LimitedASX: IPD

Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr

· Issued by Impedimed Limited

Filed with ASX · · 11 pages · English

Summary by 6ix AI

The report highlights a revenue increase compared to the previous quarter, alongside a decrease in net operating cash outflows and a cash balance that supports several quarters of operations. The company is focusing on expanding its market presence in cancer survivorship and has made significant changes in its sales leadership to enhance performance. Additionally, the report outlines the company's strategic initiatives in heart health and body composition, aiming to capture new opportunities in these segments.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Impedimed Limited on 6ix

Earlier from Impedimed

All Impedimed news releases